Andrew M. Havill - Concepedia

Author

Andrew M. Havill

Amgen (United States)

Also Known As

A M Havill, A. Havill, A. M. Havill, Andrew M Havill, Andrew M. Havill

Publications

983

Citations

H-Index

Concepts

All Affiliations

Amgen (United States)Thomas Jefferson University University of Miami

About

Andrew M. Havill is an author at Amgen (United States) specializing in medicine, acute lung injury, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	850
2	Health Sciences	3	3	485
3	Engineering	1	1	33
4	Allergy	1	1	62
5	Cell Biology	1	1	109

Andrew M. Havill

Publications

955

Citations

H-Index

Page 1

	Year	Citations
Keratinocyte growth factor protects mice from chemotherapy and radiation-induced gastrointestinal injury and mortality. Catherine L. Farrell, J. V. Bready, Karen Rex, PubMed Radiation EffectImmunologyImmune RegulationPathologyCell Death	1998	362
Prevention of bleomycin-induced lung injury in rats by keratinocyte growth factor. Robin R. Deterding, Andrew M. Havill, Takafumi Yano, PubMed Acute Lung InjuryIntratracheal Kgf PretreatmentInflammatory Lung DiseaseLung InflammationBleomycin-induced Lung Injury	1997	109
Role of intrapulmonary release of eicosanoids and superoxide anion as mediators of pulmonary dysfunction and endothelial injury in sheep with intermittent complement activation. Sandra Z. Perkowski, Andrew M. Havill, John T. Flynn, Circulation Research Acute Lung InjuryInflammatory Lung DiseaseBolus InjectionsLung InflammationImmunology	1983	100
Intravenous keratinocyte growth factor protects against experimental pulmonary injury Jane Guo, Eunhee S. Yi, Andrew M. Havill, American Journal of Physiology-Lung Cellular and Molecular Physiology Acute Lung InjuryLung InflammationIntratracheal KgfImmunologyOxidative Stress	1998	81
Inhibition of allergen-induced pulmonary responses by the selective tryptase inhibitor 1,5-bis-{4-[(3-carbamimidoyl-benzenesulfonylamino)-methyl]-phenoxy}-pentane (AMG-126737) Clifford D. Wright, Andrew M. Havill, Scot Middleton, Biochemical Pharmacology Molecular PharmacologySelective Tryptase InhibitorAllergyInflammatory Lung DiseaseLung Inflammation	1999	62
Secretory Leukocyte Protease Inhibitor Prevents Allergen-Induced Pulmonary Responses in Animal Models of Asthma Clifford D. Wright, Andrew M. Havill, Scot Middleton, Journal of Pharmacology and Experimental Therapeutics	1999	52
The relationship between pulmonary perivascular cuff fluid and lung lymph in dogs with edema M. H. Gee, Andrew M. Havill Microvascular Research Pulmonary CirculationLung LymphVeterinary ScienceLymphatic SystemPulmonary Physiology	1980	48
Prevention of non‐specific airway hyperreactivity after allergen challenge in guinea‐pigs by the PAF receptor antagonist SDZ 64–412 Andrew M. Havill, Ronald G. Van Valen, Dean A. Handley British Journal of Pharmacology	1990	40
Relationships among lung extravascular fluid compartments with alveolar flooding T. A. Zumsteg, Andrew M. Havill, M. H. Gee Journal of Applied Physiology Acute Lung InjuryMechanobiologyEngineeringEvans Blue DyeAlveolar Flooding	1982	33
Keratinocyte growth factor increases surfactant pool sizes in premature rabbits. Machiko Ikegami, AH Jobe, Andrew M. Havill American Journal of Respiratory and Critical Care Medicine Premature RabbitsHuman GrowthPathologyPulmonary Alveolar ProteinosisCell Proliferation	1997	23

Page 1